4th Quarter - Amendment
BROWN RUDNICK LLP for HOSPIRA, INC.
Firm
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 18, 2013 | $50,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 18, 2013 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011; P.L. 111-14 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S. 2295 - Patient Safety and Generic Labeling Improvement Act; Senate Draft Proposal to Improve Drug Distribution Security.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow(05-07) |
| HENRY W MENN | Min SD & Counsel, Cmte on Vet Affairs (04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.